Zinc Oxide Nanoparticles Induce an Adverse Effect on Blood Glucose Levels Depending On the Dose and Route of Administration in Healthy and Diabetic Rats

Different studies in experimental diabetes models suggest that zinc oxide nanoparticles (ZnONPs) are useful as antidiabetic agents. However, this evidence was performed and measured in long-term treatments and with repeated doses of ZnONPs. This work aimed to evaluate the ZnONPs acute effects on gly...

Descripción completa

Detalles Bibliográficos
Autores principales: Virgen-Ortiz, Adolfo, Apolinar-Iribe, Alejandro, Díaz-Reval, Irene, Parra-Delgado, Hortensia, Limón-Miranda, Saraí, Sánchez-Pastor, Enrique Alejandro, Castro-Sánchez, Luis, Jesús Castillo, Santos, Dagnino-Acosta, Adan, Bonales-Alatorre, Edgar, Rodríguez-Hernández, Alejandrina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599450/
https://www.ncbi.nlm.nih.gov/pubmed/33053624
http://dx.doi.org/10.3390/nano10102005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599450/
https://www.ncbi.nlm.nih.gov/pubmed/33053624
http://dx.doi.org/10.3390/nano10102005

Ejemplares similares